RONALD E SCHULGIT

Allopathic & Osteopathic Physicians|Family Medicine RACINE, WI NPI 1720002603

General Payments — all program years on this page

$4,526.73

  • Category: General Payments
  • Program years: PY2018–2019
  • Record count: 132
  • As of (CMS publication): 2026-01-23

Latest program year (PY2019): $1,924.78 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2019) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,917.7020
Education $7.081

By paying entity

Latest program year (PY2019) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $2,601.95111
2019 $1,924.7821

Records — PY2019 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
660169203 Novartis Pharmaceuticals Corporation $124.96 06/20/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
671105555 Allergan Inc. $77.63 06/06/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
683950375 Radius Health, Inc. $121.83 03/14/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
683950437 Radius Health, Inc. $121.83 08/06/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685274919 AstraZeneca Pharmaceuticals LP $21.62 06/05/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685296999 AstraZeneca Pharmaceuticals LP $123.30 02/06/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685340589 AstraZeneca Pharmaceuticals LP $120.36 12/10/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685695849 AstraZeneca Pharmaceuticals LP $16.68 04/24/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685849567 AstraZeneca Pharmaceuticals LP $21.56 08/28/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
694184335 SANOFI-AVENTIS U.S. LLC $97.33 11/05/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
695522057 Alexion Pharmaceuticals, Inc. $75.10 04/03/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
695522065 Alexion Pharmaceuticals, Inc. $124.87 07/30/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
699149345 Amarin Pharma Inc. $96.63 05/21/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
699267883 Amarin Pharma Inc. $124.99 12/04/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
700243715 Boehringer Ingelheim Pharmaceuticals, Inc. $111.89 06/19/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
700243717 Boehringer Ingelheim Pharmaceuticals, Inc. $124.99 03/05/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
700243719 Boehringer Ingelheim Pharmaceuticals, Inc. $101.00 03/27/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
700243721 Boehringer Ingelheim Pharmaceuticals, Inc. $120.83 07/17/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
700243723 Boehringer Ingelheim Pharmaceuticals, Inc. $7.08 08/02/2019 Education Undisputed 01/23/2026 View at CMS
703506375 Novo Nordisk Inc $124.16 06/05/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
703517461 Novo Nordisk Inc $66.14 06/12/2019 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.